Denileukin diftitox Completed Phase 2 Trials for Lymphoma, T-Cell, Peripheral Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00211185A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma